Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

191.32B

Market cap191.32B

Price-Earnings ratio

9.81

Price-Earnings ratio9.81

Dividend yield

3.06%

Dividend yield3.06%

Average volume

9.98M

Average volume9.98M

High today

$43.24

High today$43.24

Low today

$42.04

Low today$42.04

Open price

$42.43

Open price$42.43

Volume

13.18M

Volume13.18M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Benzinga 3h

Why Is Novo Nordisk Stock Surging Wednesday? - Novo Nordisk - Benzinga

...

Benzinga 3h

Novo Nordisk Raises 2026 Outlook As Wegovy Pill Shines

Novo Nordisk A/S (NYSE:NVO) stock rose Wednesday after the drugmaker reported better-than-expected third-quarter earnings and raised its full-year outlook. Nov...

Simply Wall St 3h

Is Novo Nordisk Reasonable After Its 58% Fall?

has seen its share price fall sharply in recent years, even as attention stays fixed on its diabetes and obesity franchise. With the stock down heavily over a 3...

Analyst ratings

50%

of 6 ratings

Buy

16.7%

Hold

50%

Sell

33.3%

More NVO News

The Motley Fool 4h

Viking Therapeutics Trades 23% Below Its Own $35 Secondary Offering Price. Here's Why That Could Be a Gift for Patient Investors.

Viking Therapeutics (VKTX -2.76%) has been a company to watch over the past few years. That's because the biotech is involved in one of the healthcare market's...

The Wall Street Journal 4h

Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

The Wall Street Journal 9h

Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill Continues

Wegovy pills in a manufacturing machine. Analysts had expected Novo to raise its guidance on the uptake of the pill. Novo Nordisk Novo Nordisk NOVO.B -0.02 %de...

The Motley Fool 3d

Novo Nordisk Trades at 10 Times Earnings While Buying Back Billions in Stock. Is This the Bottom?

Shares of Novo Nordisk (NVO +2.20%) have declined roughly 70% from their 2024 high. The stock is now below its level in mid-2021, when it first introduced the W...

Simply Wall St 5d

Novo Nordisk Could Be 62% Undervalued On GLP 1 Growth Expectations

Advertisement Recent Share Performance and Business Profile Novo Nordisk (NYSE:NVO) has been trading around US$39.14 per share, with the price moving higher o...

24/7 Wall St. 6d

Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases

Investing Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases Eli Lilly just posted a quarter that left...

TipRanks 7d

Novo Nordisk Advances Mim8 Trial in Rare Haemophilia A, Expanding Its Specialty Pipeline

Novo Nordisk (NVO) announced an update on their ongoing clinical study. The study “A Multinational, Open-label Study to Investigate Efficacy and Safety of Dene...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.